Quang Pham

Quang X. Pham serves as the Chairman and Chief Executive Officer of Cadrenal Therapeutics, Inc., where the focus is on developing tecarfarin, an innovative anticoagulant for patients with cardiovascular conditions. With a significant background in the biopharmaceutical industry, Quang founded Espero BioPharma, where leadership included roles as Chairman and CEO, dedicated to treatments for cardiovascular diseases. Quang's experience also encompasses strategic advisory roles and board memberships across various companies, including Cognition and Connexions Software. Educationally, Quang holds a Bachelor of Arts degree in Economics from UCLA and has a history of service as a military officer and pilot in the United States Marine Corps. Additionally, Quang is an accomplished author, having written a book recognized with the Asian Heritage Book Award.